Inventor
Manami Shizuka
Inventor
Belmont, MA, US
Overview
Patents· 24 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
A61KPreparations for medical, dental or toiletry purposes17%
C07KPeptides16%
C07CAcyclic or carbocyclic compounds9%
Y02PClimate change mitigation technologies in the production or processing of goods9%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%
C07BGeneral methods of organic chemistry2%
PatentTitleYear
11,116,845Cytotoxic benzodiazepine derivatives202110,988,531Conjugates comprising cell-binding agents and cytotoxic agents202110,968,228Methods of preparing substituted 12a,13-dihydro-6H-benzo[5,6][1,4]diazepino[1,2-a]indoles202110,899,775Methods of preparing cytotoxic benzodiazepine derivatives202110,844,078Methods of preparing cytotoxic benzodiazepine derivatives202010,787,463Methods of preparing cytotoxic benzodiazepine derivatives202010,722,588Cytotoxic benzodiazepine derivatives202010,442,809Methods for preparing substituted 12a,13-dihydro-6H-benzo[5,6][1,4]diazepino[1,2-a]indol-6-ones201910,392,407Methods of preparing cytotoxic benzodiazepine derivatives201910,385,071Methods of preparing cytotoxic benzodiazepine derivatives201910,370,389Methods of preparing cytotoxic benzodiazepine derivatives201910,238,751Cytotoxic benzodiazepine derivatives201910,081,640Methods of preparing cytotoxic benzodiazepine derivatives20189,974,867Cytotoxic benzodiazepine derivatives20189,890,179'Methods of preparing cytotoxic benzodiazepine derivatives'20189,873,708Methods of preparing cytotoxic benzodiazepine derivatives20189,682,978'2,6,7 substituted purines as HDM2 inhibitors'20179,669,102'Cytotoxic benzodiazepine derivatives'20179,540,377'2,6,7,8 substituted purines as HDM2 inhibitors'20179,381,256'Cytotoxic benzodiazepine derivatives'20169,062,071'Substituted piperidines as HDM2 inhibitors'20158,962,611'Substituted imidazopyridines as HDM2 inhibitors'20158,859,776'Substituted piperidines that increase p53 activity and the uses thereof'20148,846,657'Substituted imidazopyridines as HDM2 inhibitors'2014Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2014–2017Patents assigned to MERCK SHARP & DOHME (6)· patent assignee history
2014Patents assigned to BOGEN STEPHANE L (1)· patent assignee history
2014Patents assigned to DOLL RONALD J (1)· patent assignee history
2014Patents assigned to GIBEAU CRAIG R (1)· patent assignee history
2014–2017Based in Lexington, MA, US· patent location history
2016–2021Patents assigned to IMMUNOGEN INC (18)· patent assignee history
2016–2021Based in Belmont, MA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IMMUNOGEN INC | 18 | 2016–2021 |
| MERCK SHARP & DOHME | 6 | 2014–2017 |
| BOGEN STEPHANE L | 1 | 2014 |
| DOLL RONALD J | 1 | 2014 |
| GIBEAU CRAIG R | 1 | 2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Belmont, Massachusetts, US | 18 | 2016–2021 |
| Lexington, Massachusetts, US | 6 | 2014–2017 |